BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16733455)

  • 1. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
    Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrodermatitis dysmetabolica in an infant with maple syrup urine disease.
    Flores K; Chikowski R; Morrell DS
    Clin Exp Dermatol; 2016 Aug; 41(6):651-4. PubMed ID: 27334242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrodermatitis enteropathica-like syndrome secondary to isoleucine deficiency during treatment of maple syrup urine disease.
    Giacoia GP; Berry GT
    Am J Dis Child; 1993 Sep; 147(9):954-6. PubMed ID: 8362810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iatrogenic acrodermatitis enteropathica-like syndrome in leucinosis].
    Puzenat E; Durbise E; Fromentin C; Humbert P; Aubin F
    Ann Dermatol Venereol; 2004; 131(8-9):801-4. PubMed ID: 15505548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
    Tain YL; Huang SC; Hung FC; Wang HS; Sun PC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):357-60. PubMed ID: 8942030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrodermatitis enteropathica-like cutaneous lesions in organic aciduria.
    De Raeve L; De Meirleir L; Ramet J; Vandenplas Y; Gerlo E
    J Pediatr; 1994 Mar; 124(3):416-20. PubMed ID: 8120711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrodermatitis enteropathica-like eruption in an infant with nonketotic hyperglycinemia.
    Samady JA; Schwartz RA; Shih LY; Piela Z; Lambert WC; Janniger CK
    J Dermatol; 2000 Sep; 27(9):604-8. PubMed ID: 11052237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoleucine Deficiency in a Neonate Treated for Maple Syrup Urine Disease Masquerading as Acrodermatitis Enteropathica.
    Ross B; Kumar M; Srinivasan H; Ekbote AV
    Indian Pediatr; 2016 Aug; 53(8):738-40. PubMed ID: 27567652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency in inborn errors of metabolism.
    Oztürk Y
    Pediatr Dermatol; 2008; 25(3):415. PubMed ID: 18577070
    [No Abstract]   [Full Text] [Related]  

  • 10. Iatrogenic isolated isoleucine deficiency as the cause of an acrodermatitis enteropathica-like syndrome.
    Bosch AM; Sillevis Smitt JH; Van Gennip AH; Abeling NG; Schutgens RB; Bakker HD; Wijburg FA
    Br J Dermatol; 1998 Sep; 139(3):488-91. PubMed ID: 9767296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrodermatitis enteropathica-like eruption in metabolic disorders: acrodermatitis dysmetabolica is proposed as a better term.
    Tabanlioğlu D; Ersoy-Evans S; Karaduman A
    Pediatr Dermatol; 2009; 26(2):150-4. PubMed ID: 19419460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrodermatitis dysmetabolica secondary to isoleucine deficiency in infant with maple syrup urine disease.
    Alkhayal FA; Al Haddad S; Bakraa RM; Alqahtani A
    Dermatol Reports; 2023 Dec; 15(4):9750. PubMed ID: 38327590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
    Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maple Syrup Urine Disease Complicated with Kyphoscoliosis and Myelopathy.
    Hou JW
    Pediatr Neonatol; 2016 Oct; 57(5):431-435. PubMed ID: 24486081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
    Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
    Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIETARY TREATMENT OF A CHILD WITH MAPLE SYRUP URINE DISEASE (BRANCHED-CHAIN KETOACIDURIA).
    WESTALL RG
    Arch Dis Child; 1963 Oct; 38(201):485-91. PubMed ID: 14065992
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
    Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
    Skaper SD; Molden DP; Seegmiller JE
    Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.